Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker | Zendy

Andreas Schuchert | Zendy; Carmine Muto | Zendy; Themistoklis Maounis | Zendy; Robert Frank | Zendy; E. Boulogne | Zendy; Alexander Polauck | Zendy; Luigi Padeletti | Zendy

Open Access

Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker

Author(s) -

Andreas Schuchert,

Carmine Muto,

Themistoklis Maounis,

Robert Frank,

E. Boulogne,

Alexander Polauck,

Luigi Padeletti

Publication year - 2012

Publication title -

ep europace

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1093/europace/eus247

Subject(s) - cardiac resynchronization therapy , medicine , implantable cardioverter defibrillator , cardiology , implant , artificial cardiac pacemaker , incidence (geometry) , heart failure , lead (geology) , surgery , ejection fraction , physics , optics , geomorphology , geology

The decision to implant a cardiac resynchronization therapy (CRT) system with (defibrillator, CRT-D) or without (pacemaker, CRT-P) cardioverter defibrillator should weigh its benefits and risks. This study examined the (i) incidence of loss of capture and infectious complications and (ii) 1-year clinical outcomes of 402 CRT-D and CRT-P recipients enrolled in the MASCOT study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research